Artificial intelligence based virtual screening study for competitive and allosteric inhibitors of the SARS-CoV-2 main protease

S Charles, MP Edgar, RK Mahapatra - Journal of Biomolecular …, 2023 - Taylor & Francis
SARS-CoV-2 is a highly contagious and dangerous coronavirus that first appeared in late
2019 causing COVID-19, a pandemic of acute respiratory illnesses that is still a threat to …

Structure-based virtual screening and biochemical validation to discover a potential inhibitor of the SARS-CoV-2 main protease

A Gupta, C Rani, P Pant, V Vijayan, N Vikram… - ACS …, 2020 - ACS Publications
The recent pandemic caused by SARS-CoV-2 has led the world to a standstill, causing a
medical and economic crisis worldwide. This crisis has triggered an urgent need to discover …

Identification of SARS‐CoV‐2 Main Protease Inhibitors Using Structure Based Virtual Screening and Molecular Dynamics Simulation of DrugBank Database

P Debnath, S Bhaumik, D Sen, RK Muttineni… - …, 2021 - Wiley Online Library
Abstract Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) is highly
pathogenic to humans and has created an unprecedented global health care threat …

[HTML][HTML] Screening of potential inhibitors targeting the main protease structure of SARS-CoV-2 via molecular docking

X Yang, X Xing, Y Liu, Y Zheng - Frontiers in Pharmacology, 2022 - frontiersin.org
The novel coronavirus disease (COVID-19) caused by SARS-CoV-2 virus spreads rapidly to
become a global pandemic. Researchers have been working to develop specific drugs to …

Virtual screening, ADMET prediction and dynamics simulation of potential compounds targeting the main protease of SARS-CoV-2

R Yadav, M Imran, P Dhamija… - Journal of …, 2021 - Taylor & Francis
The coronavirus disease-2019 caused by a novel SARS CoV-2 virus has emerged as a
global threat. Still, no drugs are available for its treatment. The main protease is the most …

Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors

A Jimenez-Alberto, RM Ribas-Aparicio… - … biology and chemistry, 2020 - Elsevier
The global emergency caused by COVID-19 makes the discovery of drugs capable of
inhibiting SARS-CoV-2 a priority, to reduce the mortality and morbidity of this disease …

Finding potent inhibitors against SARS-CoV-2 main protease through virtual screening, ADMET, and molecular dynamics simulation studies

R Roy, MF Sk, NA Jonniya, S Poddar… - Journal of Biomolecular …, 2022 - Taylor & Francis
Currently, no antiviral drug or vaccine is available to treat COVID-19 caused by SARS-CoV-
2. This underscores an urgent need for developing a drug against SARS-CoV-2. The main …

Virtual screening and structure-based 3D pharmacophore approach to identify small-molecule inhibitors of SARS-CoV-2 Mpro

SA Elseginy - Journal of Biomolecular Structure and Dynamics, 2022 - Taylor & Francis
The outbreak caused by a coronavirus 2 has required quick and potential treatment
strategies. The main protease enzyme Mpro plays an important role in the viral replication …

Structure-based identification of potential SARS-CoV-2 main protease inhibitors

S Khan, Z Fakhar, A Hussain, A Ahmad… - Journal of …, 2022 - Taylor & Francis
To address coronavirus disease (COVID-19), currently, no effective drug or vaccine is
available. In this regard, molecular modeling approaches are highly useful to discover …

Targeting SARS-CoV-2 main protease: structure based virtual screening, in silico ADMET studies and molecular dynamics simulation for identification of potential …

A Uniyal, MK Mahapatra, V Tiwari… - Journal of …, 2022 - Taylor & Francis
COVID-19 pandemic has created a healthcare crisis across the world and has put human
life under life-threatening circumstances. The recent discovery of the crystallized structure of …